Portal de Periódicos da CAPES

Pathogenetic mechanisms in thyroid‐associated ophthalmopathy

1992; Wiley; Volume: 231; Issue: 3 Linguagem: Inglês

10.1111/j.1365-2796.1992.tb00525.x

1365-2796

Petros Perros, P. Kendall‐Taylor,

Child Abuse and Related Trauma

Journal of Internal MedicineVolume 231, Issue 3 p. 205-211 Pathogenetic mechanisms in thyroid-associated ophthalmopathy Dr. P. PERROS, Corresponding Author Dr. P. PERROS Endocrine Unit, Department of Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UKEndocrine Unit, Department of Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this authorP. KENDALL-TAYLOR, P. KENDALL-TAYLOR Endocrine Unit, Department of Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UKSearch for more papers by this author Dr. P. PERROS, Corresponding Author Dr. P. PERROS Endocrine Unit, Department of Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UKEndocrine Unit, Department of Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK.Search for more papers by this authorP. KENDALL-TAYLOR, P. KENDALL-TAYLOR Endocrine Unit, Department of Medicine, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UKSearch for more papers by this author First published: March 1992 https://doi.org/10.1111/j.1365-2796.1992.tb00525.xCitations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Salvi M., Zhang Z-G, Haegert D. et al. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 1990; 70: 89–93. 10.1210/jcem-70-1-89 CASPubMedWeb of Science®Google Scholar 2 Hales IB, Rundle FF. Ocular changes in Graves disease. Quart J Med 1960; 29: 113–26. CASPubMedWeb of Science®Google Scholar 3 Streeten D., Anderson G., Reed G., Woo P. Prevalence, natural history and surgical treatment of exophthalmos. Clin Endocrinol 1987; 27: 125–33. 10.1111/j.1365-2265.1987.tb00848.x CASPubMedWeb of Science®Google Scholar 4 Werner S., Coleman DJ, Franzen LA. Ultrasonographic evidence of a consistent orbital involvement in Graves disease. N Engl J Med 1974; 290: 1447–50. 10.1056/NEJM197406272902602 CASPubMedWeb of Science®Google Scholar 5 Enzmann DR, Donaldson S., Kriss JP. Appearance of Graves disease on orbital computed tomography. J Comput Assist Tomogr 1979; 3: 815–9. 10.1097/00004728-197903060-00019 CASPubMedWeb of Science®Google Scholar 6 Gamblin G., Harper D., Galentine P., Buck D., Chernow B., Eil C. Prevalence of increased intraocular pressure in Graves disease—evidence of frequent subclinical ophthalmopathy. N Engl J Med 1983; 308: 420–4. 10.1056/NEJM198302243080803 CASPubMedWeb of Science®Google Scholar 7 Kroll AJ, Kuwabara T. Dysthyroid ocular myopathy. Arch Ophthalmol 1966; 76: 244–56. 10.1001/archopht.1966.03850010246017 CASPubMedWeb of Science®Google Scholar 8 Riley FC. Orbital pathology in Graves disease. Mayo Clin Proc 1972; 47: 975–9. Web of Science®Google Scholar 9 Hufnagel TJ, Hickey WF, Cobbs NH, Jacobiec FA, Iwamoto T., Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves disease. Ophthalmology 1984; 91: 1411–9. 10.1016/S0161-6420(84)34152-5 PubMedWeb of Science®Google Scholar 10 Small RG. Enlargement of levator palpebrae superioris muscle fibres in Graves ophthalmopathy. Ophthalmology 1989; 96: 424–30. 10.1016/S0161-6420(89)32874-0 CASPubMedWeb of Science®Google Scholar 11 Solem JH, Segaard E., Ytteborg J. The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study. Acta Med Scand 1979; 205: 111–4. 10.1111/j.0954-6820.1979.tb06012.x CASPubMedWeb of Science®Google Scholar 12 Prummel MF, Wirsinga WM, Murits MP, Koornneef L., Berghout A., Van der Gaag R. Effect of abnormal thyroid function on the severity of Graves ophthalmopathy. Arch Intern Med 1990; 150: 1098–101. 10.1001/archinte.150.5.1098 CASPubMedWeb of Science®Google Scholar 13 Teng C., Yeo P. Ophthalmic Graves disease: natural history and detailed thyroid function tests. BMJ 1977; 1: 273–5. 10.1136/bmj.1.6056.273 CASPubMedWeb of Science®Google Scholar 14 Marcocci C., Bartalena L., Bogazzi F., Panicucci M., Pinchera A. Studies on the occurrence of ophthalmopathy in Graves disease. Acta Endocrinol 1989; 120: 473–8. CASPubMedWeb of Science®Google Scholar 15 Miller JE. Acquired strabismus in adults. South Med J 1961; 54: 744–52. 10.1097/00007611-196107000-00008 CASPubMedWeb of Science®Google Scholar 16 Gorman C. Temporal relationship between onset of Graves ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 1983; 58: 515–9. CASPubMedWeb of Science®Google Scholar 17 Mahieu P., Winand R. Demonstration of delayed hyper-sensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab 1972; 34: 1090. 10.1210/jcem-34-6-1090 PubMedWeb of Science®Google Scholar 18 Munro DE, Lamki L., Row VV, Volpe R. Cell mediated immunity in the exophthalmos of Graves disease as demonstrated by the MIF test. J Clin Endocrinol Metab 1973; 37: 286–92. 10.1210/jcem-37-2-286 CASPubMedWeb of Science®Google Scholar 19 Kodama K., Bandy-Dafoe P., Sikorska H., Bayly R., Wall JR. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves ophthalmopathy. Lancet 1982; ii: 1353–6. 10.1016/S0140-6736(82)91267-3 CASGoogle Scholar 20 Kendall-Taylor P., Atkinson S., Holcombe M. A specific IgG in Graves ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. BMJ 1984; 288: 1183–6. 10.1136/bmj.288.6425.1183 CASPubMedWeb of Science®Google Scholar 21 Faryna M., Nauman J., Gardas A. Measurement of auto-antibodies against human eye muscle plasma membranes in Graves ophthalmopathy. BMJ 1985; 290: 191–2. 10.1136/bmj.290.6463.191 CASPubMedWeb of Science®Google Scholar 22 Bahn RS, Gorman CA, Woloschak GE, David CS, Johnson PM, Johnson CM. Human retroocular fibroblasts in vitro. A model for the study of Graves ophthalmopathy. J Clin Endocrinol Metab 1987; 65: 665–70. 10.1210/jcem-65-4-665 CASPubMedWeb of Science®Google Scholar 23 Singer J. Neonatal thyrotoxicosis. J Pediatr 1977; 91: 749–51. 10.1016/S0022-3476(77)81028-7 CASPubMedWeb of Science®Google Scholar 24 Holland FJ, McConnon JK, Volpe R., Saunders EF. Concordant Graves disease after bone marrow transplantation: implications for pathogenesis. J Clin Endocrinol Metab 1991; 72: 837–40. 10.1210/jcem-72-4-837 CASPubMedWeb of Science®Google Scholar 25 Dudgeon LS, Urquhart AL. Lymphorrhages in the muscle in exophthalmic goitre. Brain 1925; XLIX: 182–6. Google Scholar 26 Friedenwald JS. Orbital myositis and choked disk in exophthalmic goitre. Ann Surg 1932; 96: 995–7. 10.1097/00000658-193212000-00005 CASPubMedGoogle Scholar 27 Naffziger H. Pathologic changes in the orbit in progressive exophthalmos. Arch Ophthalmol 1933; 9: 1–12. 10.1001/archopht.1933.00830010004001 Web of Science®Google Scholar 28 Martinez AJ, McNeer KW, Hay SH, Watson A. Extraocular muscles: morphogenetic study in humans. Light microscopy and ultrastructural features. Acta Neuropathol 1977; 38: 87–93. 10.1007/BF00688553 CASPubMedWeb of Science®Google Scholar 29 Ringel SP, Wilson WB, Barden M., Kaiser K. Histochemistry of human extraocular muscle. Arch Ophthalmol 1978; 96: 1067–72. 10.1001/archopht.1978.03910050587020 CASPubMedWeb of Science®Google Scholar 30 Tallstedt L., Norberg R. Immunohistochemical staining of normal and Graves extraocular muscle. Invest Ophthalmol Vis Sci 1988; 29: 175–84. CASPubMedWeb of Science®Google Scholar 31 Weetman A., Cohen S., Gatter K., Fells P., Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves ophthalmopathy. Clin Exp Immunol 1989; 75: 222–7. CASPubMedWeb of Science®Google Scholar 32 Sevel D. The origins and insertions of the extraocular muscles: development, histological features, and clinical significance. Trans Am Ophthalmol Soc 1986; 84: 488–526. CASPubMedGoogle Scholar 33 Wierczorck DF, Periasamy M., Butler-Browne GS, Whalen RG, Nadal-Ginard B. Coexpression of multiple myosin heavy chain genes in addition to tissue specific ones in extraocular musculature. J Cell Biol 1985; 101: 618–29. 10.1083/jcb.101.2.618 CASPubMedWeb of Science®Google Scholar 34 Briggs MM, Jakoby J., Davidowitz J., Schachat FH. Expression of a novel combination of fast and slow Troponin C isoforms in rabbit extraocular muscles. J Muscle Res Cell Motil 1988; 9: 241–7. 10.1007/BF01773894 CASPubMedWeb of Science®Google Scholar 35 Smith T., Bahn R., Gorman CA. Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retro-ocular and dermal fibroblasts. J Clin Endocrinol Metab 1989; 69: 1019–23. 10.1210/jcem-69-5-1019 CASPubMedWeb of Science®Google Scholar 36 Smith TJ, Bahn RS, Gorman CA, Cheavens M. Stimulation of glycosoaminoglycan accumulation by interferon gamma in cultured retro-ocular fibroblasts. J Clin Endocrinol Metab 1991; 72: 1169–71. 10.1210/jcem-72-5-1169 CASPubMedWeb of Science®Google Scholar 37 Lanzavecchia A. Clonal sketches of the immune response. EMBO J 1988; 7: 2945. 10.1002/j.1460-2075.1988.tb03156.x CASPubMedWeb of Science®Google Scholar 38 DeGroot LJ, Quintans, J. The causes of autoimmune thyroid disease. Endocr Rev 1989; 10: 537–62. 10.1210/edrv-10-4-537 CASPubMedWeb of Science®Google Scholar 39 Nakamura M., Burastero S., Ueki Y., Larrick J., Notkins A., Casali P. Probing the normal and autoimmune B cell repertoire with Ebstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimotos disease and systemic lupus erythematosus. J Immunol 1988; 141: 4165. PubMedWeb of Science®Google Scholar 40 Volpe R. The role of autoimmunity in hypoendocrine and hyperendocrine function. Ann Intern Med 1977; 87: 86–99. 10.7326/0003-4819-87-1-86 CASPubMedWeb of Science®Google Scholar 41 Oldstone M. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819–20. 10.1016/0092-8674(87)90507-1 CASPubMedWeb of Science®Google Scholar 42 How J., Miller A., Laryea E., Wall J. Studies of cell-mediated immunity in Graves ophthalmopathy using the antigeninduced leukocyte procoagulant activity assay. In: HA Drexhage, WM Wiersinga. eds. Proceedings of an International Symposium on the Thyroid and Autoimmunity. International Congress Series No. 711. Amsterdam: Elsevier, 1986; 270–71. Google Scholar 43 Van der Gaag R., Vernimmen R., Fiebelkorn N., Diercndonck van MC, Kijlstra A. Graves ophthalmopathy: what is the evidence for extraocular muscle specific antibodies Int Ophthalmol 1990; 14: 25–30. 10.1007/BF00131165 PubMedWeb of Science®Google Scholar 44 Wang PW, Hiromatsu Y., Larya E., Wosu L., How J., Wall JR. Immunologically mediated cytotoxicity against human eye muscle cells in Graves ophthalmopathy. J Clin Endocrinol Metab 1986; 63: 316–22. 10.1210/jcem-63-2-316 CASPubMedWeb of Science®Google Scholar 45 Hiromatsu Y., Cadarso L., Salvi M., Wall JR. Signiticance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathy. Autoimmunity 1990; 5: 205–13. 10.3109/08916939009002979 CASPubMedWeb of Science®Google Scholar 46 Salvi M., Fukazawa H., Bernard N., Hiromatsu Y., How J., Wall J. Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders. Endocr Rev 1988; 9: 450–66. 10.1210/edrv-9-4-450 CASPubMedWeb of Science®Google Scholar 47 Ludgate M., Dong Q., Dreyfus P. et al. Definition at the molecular level of a thyroglobulin-acetylcholinesterase shared epitope: study of its pathophysiological significance in patients with Graves ophthalmopathy. Autoimmunity 1989; 3: 167–76. 10.3109/08916938909099014 CASPubMedWeb of Science®Google Scholar 48 Wall JR, Salvi M., Bernard F., Boucher A., Haegert D. Thyroid-associated ophthalmopathy—a model for the association of organ-specific autoimmune disorders. Immunol Today 1991; 12: 150–53. 10.1016/S0167-5699(05)80044-1 CASPubMedWeb of Science®Google Scholar 49 Bahn RS, Gorman CA, Johnston CM, Smith TJ. Presence of antibodies in the sera of patients with Graves disease recognizing a 23 kilodalton fibroblast protein. J Clin Endocrinol Metab 1989; 69: 622–8. 10.1210/jcem-69-3-622 CASPubMedWeb of Science®Google Scholar 50 Rotella CM, Zonefrati R., Toccafondi R., Valente WA, Kohn LD. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts. An assay which appears to measure exophthalmogenic immunoglobulins in Graves sera. J Clin Endocrinol Metab 1986; 62: 357–67. 10.1210/jcem-62-2-357 CASPubMedWeb of Science®Google Scholar 51 Hansson HA, Petruson B., Skottner A. Somatomedin C in the pathogenesis of malignant exophthalmos of endocrine origin. Lancet 1986; 2: 218–9. 10.1016/S0140-6736(86)90698-7 CASGoogle Scholar 52 Baxter RC. The somatomedins: insulin-like growth factors. Adv Clin Chem 1986; 25: 49–115. 10.1016/S0065-2423(08)60124-9 CASPubMedWeb of Science®Google Scholar 53 Bech K., Lumholtz B., Nerup J. et al. HLA antigens in Graves disease. Acta Endocrinol 1977; 86: 510–6. PubMedWeb of Science®Google Scholar 54 Frecker M., Stenszky V., Balazs C., Kozma L., Kraszits E., Farid N. Genetic factors in Graves ophthalmopathy. Clin Endocrinol 1986; 25: 479–85. 10.1111/j.1365-2265.1986.tb03599.x CASPubMedWeb of Science®Google Scholar 55 Kendall-Taylor P., Stephenson A., Stratton A., Papiha S., Perros P., Roberts D. Differentiation of autoimmune ophthalmopathy from Graves hyperthyroidism by genetic markers. Clin Endocrinol 1988; 28: 601–24. 10.1111/j.1365-2265.1988.tb03851.x CASPubMedWeb of Science®Google Scholar 56 Hagg E., Asplund K. Is endocrine ophthalmopathy related to smoking BMJ 1987; 295: 634. 10.1136/bmj.295.6599.634 CASPubMedWeb of Science®Google Scholar 57 Bartalena L., Marcocci C., Bogazzi F., Panicucci M., Lepra A., Pinchera A. Use of corticosteroids to prevent progression of Graves ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989; 321: 1349–52. 10.1056/NEJM198911163212001 PubMedWeb of Science®Google Scholar 58 Shine B., Fells P., Edwards OM, Weetman AP. Association between Graves ophthalmopathy and smoking. Lancet 1990; 335: 1261–3. 10.1016/0140-6736(90)91315-2 PubMedWeb of Science®Google Scholar 59 Saxena K., Crawford J., Talbot N. Childhood thyrotoxicosis: a long-term perspective. BMJ 1964; 2: 1153–8. 10.1136/bmj.2.5418.1153 CASPubMedWeb of Science®Google Scholar 60 Young LA. Dysthyroid ophthalmopathy in children. J Pediatr Ophthalmol Strabismus 1978; 16: 105–7. Web of Science®Google Scholar 61 Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy. Arch Ophthalmol 1978; 96: 1199–209. 10.1001/archopht.1978.03910060033007 CASPubMedWeb of Science®Google Scholar 62 Kriss J., Pleshakov V., Rosenblum A., Holderness M., Sharp G., Utiger R. Studies on the pathogenesis of the ophthalmopathy of Graves disease. J Clin Endocrinol 1967; 27: 582–93. 10.1210/jcem-27-4-582 CASPubMedWeb of Science®Google Scholar 63 Vestergaard H., Laurberg P. Radioiodine and aggravation of Graves ophthalmopathy. Lancet 1989; 2: 47. 10.1016/S0140-6736(89)90288-2 CASPubMedWeb of Science®Google Scholar 64 Bartalena L., Martino E., Marcocci C. et al. More on smoking and Graves ophthalmopathy. J Endocrinol Invest 1989; 12: 733–7. 10.1007/BF03350047 PubMedWeb of Science®Google Scholar 65 Gwinup G., Elias AN, Ascher MS. Effect on exophthalmos of various methods of treatment of Graves disease. J Am Med Assoc 1982; 247: 2135–8. 10.1001/jama.247.15.2135 CASPubMedWeb of Science®Google Scholar 66 Sridama V., DeGroot LJ. Treatment of Graves disease and the course of ophthalmopathy. Am J Med 1989; 87: 70–73. 10.1016/S0002-9343(89)80485-1 PubMedWeb of Science®Google Scholar 67 McGregor AM, Petersen MM, Capiferri R., Evered DC, Smith BR, Hall R. Effects of radioiodine on thyrotropin binding inhibiting immunoglobulins in Graves disease. Clin Endocrinol 1979; 11: 437–44. 10.1111/j.1365-2265.1979.tb03095.x CASPubMedWeb of Science®Google Scholar 68 Shishiba Y., Yanagishita M., Hascall V. Effect of thyroid hormone deficiency on proteoglycan synthesis by human skin fibroblast cultures. Connect Tissue Res 1988; 17: 119–35. 10.3109/03008208809015024 CASPubMedWeb of Science®Google Scholar Citing Literature Volume231, Issue3March 1992Pages 205-211 ReferencesRelatedInformation